Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples